Titan Medical (TSE:TMD) Sets New 52-Week Low at $0.06

Titan Medical Inc. (TSE:TMD)’s stock price reached a new 52-week low on Monday . The company traded as low as C$0.06 and last traded at C$0.06, with a volume of 82195 shares trading hands. The stock had previously closed at C$0.06.

Titan Medical Price Performance

The firm’s fifty day simple moving average is C$0.08 and its 200-day simple moving average is C$0.09. The firm has a market capitalization of C$6.77 million, a PE ratio of -1.50 and a beta of 2.03. The company has a quick ratio of 1.18, a current ratio of 4.92 and a debt-to-equity ratio of 19.07.

Titan Medical (TSE:TMD) last announced its quarterly earnings data on Monday, April 1st. The company reported C($0.04) earnings per share for the quarter. Titan Medical had a negative return on equity of 24.94% and a negative net margin of 10.93%. On average, research analysts forecast that Titan Medical Inc. will post -1.9800001 earnings per share for the current fiscal year.

Titan Medical Company Profile

Titan Medical Inc, a medical technology company, focuses on the development and commercialization of robotic assisted surgical technologies for application in minimally invasive surgery. It is developing the Enos system, a robotic single access surgical system that includes a surgeon-controlled patient cart comprising a 3D high-definition vision system and multi-articulating instruments for performing surgical procedures; and a surgeon workstation that provides the surgeon with ergonomic interface to the patient cart and a 3D endoscopic view inside the patient's body during surgical procedures.